Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Labviva
United States
- Boston, Massachusetts
- 28/03/2023
- Series A
- $20,000,000
Revolutionizing life sciences procurement.
AI-powered digital marketplace for complete transparency into your supply chain
Labviva integrates with your existing purchasing software to provide you with actionable insights to make better decisions.
Keep your current suppliers, contract pricing, and your purchasing software and processes. Our digital marketplace offers unparalleled visibility into your procurement process, to empower informed decisions to drive science forward without interruptions to your research.
- Industry Biotechnology
- Website https://www.labviva.com/
- LinkedIn https://www.linkedin.com/company/labviva/
Related People
Siamak BaharlooCo Founder
United States -
Greater Boston
Labviva is a digital marketplace for life science products connecting researchers with suppliers of reagents, chemicals, and instrumentation. We create a unique relationship between scientific content and products across hundreds of brands and suppliers resulting in a seamless purchasing experience.
https://www.labviva.com/
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)